Genmab A/S (OTCMKTS:GNMSF - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $208.77 and traded as high as $216.40. Genmab A/S shares last traded at $216.40, with a volume of 8 shares changing hands.
Genmab A/S Stock Down 2.7%
The stock has a market capitalization of $13.80 billion, a P/E ratio of 11.84 and a beta of 0.91. The firm has a fifty day moving average price of $209.58 and a two-hundred day moving average price of $205.96.
Genmab A/S (OTCMKTS:GNMSF - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $3.05 EPS for the quarter, beating the consensus estimate of $1.88 by $1.17. Genmab A/S had a return on equity of 19.23% and a net margin of 35.11%. The company had revenue of $765.14 million for the quarter, compared to analysts' expectations of $761.09 million.
About Genmab A/S
(
Get Free Report)
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.
See Also
Before you consider Genmab A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genmab A/S wasn't on the list.
While Genmab A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
